4//SEC Filing
Lacey David L. 4
Accession 0001209191-22-027666
CIK 0001549595other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:40 PM ET
Size
5.5 KB
Accession
0001209191-22-027666
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Director Stock Option (right to buy)
2022-05-05+17,500→ 17,500 totalExercise: $10.39Exp: 2032-05-04→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 5, 2023, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001734422
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 5:40 PM ET
- Size
- 5.5 KB